Financial Management Professionals’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $5.76K | Buy |
100
+47
| +89% | +$2.7K | ﹤0.01% | 664 |
|
|
2026
Q1 | $3.21K | Sell |
53
-3
| -5% | -$175 | ﹤0.01% | 666 |
|
|
2025
Q4 | $3.02K | Sell |
56
-19
| -25% | -$914 | ﹤0.01% | 668 |
|
|
2025
Q3 | $3.38K | Sell |
75
-56
| -43% | -$2.62K | ﹤0.01% | 640 |
|
|
2025
Q2 | $6.06K | Sell |
131
-373
| -74% | -$18.3K | ﹤0.01% | 606 |
|
|
2025
Q1 | $30.7K | Buy |
504
+102
| +25% | +$5.95K | ﹤0.01% | 333 |
|
|
2024
Q4 | $22.7K | Buy |
402
+18
| +5% | +$1.01K | ﹤0.01% | 386 |
|
|
2024
Q3 | $20K | Buy |
384
+71
| +23% | +$3.33K | ﹤0.01% | 420 |
|
|
2024
Q2 | $13K | Buy |
313
+123
| +65% | +$5.5K | ﹤0.01% | 450 |
|
|
2024
Q1 | $10K | Sell |
190
-81
| -30% | -$4.13K | ﹤0.01% | 531 |
|
|
2023
Q4 | $14K | Sell |
271
-3,322
| -92% | -$174K | ﹤0.01% | 479 |
|
|
2023
Q3 | $209K | Sell |
3,593
-473
| -12% | -$29K | 0.04% | 113 |
|
|
2023
Q2 | $260K | Sell |
4,066
-1,322
| -25% | -$88.6K | 0.04% | 106 |
|
|
2023
Q1 | $373K | Buy |
5,388
+961
| +22% | +$67.8K | 0.07% | 83 |
|
|
2022
Q4 | $319K | Buy |
4,427
+499
| +13% | +$37.6K | 0.07% | 84 |
|
|
2022
Q3 | $279K | Sell |
3,928
-1,463
| -27% | -$106K | 0.06% | 75 |
|
|
2022
Q2 | $415K | Buy |
5,391
+222
| +4% | +$16.9K | 0.1% | 62 |
|
|
2022
Q1 | $378K | Buy |
5,169
+2,866
| +124% | +$192K | 0.08% | 69 |
|
|
2021
Q4 | $144K | Sell |
2,303
-29
| -1% | -$1.7K | 0.03% | 125 |
|
|
2021
Q3 | $138K | Buy |
2,332
+124
| +6% | +$8.17K | 0.03% | 112 |
|
|
2021
Q2 | $148K | Buy |
2,208
+248
| +13% | +$16.2K | 0.04% | 109 |
|
|
2021
Q1 | $124K | Buy |
1,960
+548
| +39% | +$34.1K | 0.03% | 105 |
|
|
2020
Q4 | $88K | Sell |
1,412
-96
| -6% | -$5.9K | 0.02% | 141 |
|
|
2020
Q3 | $91K | Buy |
1,508
+7
| +0.5% | +$421 | 0.03% | 118 |
|
|
2020
Q2 | $88K | Buy |
1,501
+1,224
| +442% | +$73.2K | 0.03% | 115 |
|
|
2020
Q1 | $15K | Sell |
277
-51
| -16% | -$3.12K | 0.01% | 150 |
|
|
2019
Q4 | $21K | Buy |
328
+127
| +63% | +$7.27K | 0.01% | 142 |
|
|
2019
Q3 | $10K | Buy |
201
+51
| +34% | +$2.4K | ﹤0.01% | 179 |
|
|
2019
Q2 | $7K | Hold |
150
| – | – | ﹤0.01% | 216 |
|
|
2019
Q1 | $7K | Hold |
150
| – | – | ﹤0.01% | 180 |
|
|
2018
Q4 | $8K | Hold |
150
| – | – | 0.01% | 161 |
|
|
2018
Q3 | $9K | Hold |
150
| – | – | ﹤0.01% | 182 |
|
|
2018
Q2 | $8K | Hold |
150
| – | – | ﹤0.01% | 170 |
|
|
2018
Q1 | $9K | Hold |
150
| – | – | ﹤0.01% | 167 |
|
|
2017
Q4 | $9K | Hold |
150
| – | – | ﹤0.01% | 136 |
|
|
2017
Q3 | $9K | Hold |
150
| – | – | ﹤0.01% | 138 |
|
|
2017
Q2 | $8K | Hold |
150
| – | – | ﹤0.01% | 163 |
|
|
2017
Q1 | $8K | Hold |
150
| – | – | ﹤0.01% | 182 |
|
|
2016
Q4 | $8K | Hold |
150
| – | – | ﹤0.01% | 174 |
|
|
2016
Q3 | $8K | Sell |
150
-71
| -32% | -$4.56K | ﹤0.01% | 190 |
|
|
2016
Q2 | $16K | Buy |
221
+71
| +47% | +$5.02K | 0.01% | 157 |
|
|
2016
Q1 | $10K | Hold |
150
| – | – | 0.01% | 146 |
|
|
2015
Q4 | $10K | Hold |
150
| – | – | 0.01% | 146 |
|
|
2015
Q3 | $9K | Hold |
150
| – | – | 0.01% | 164 |
|
|
2015
Q2 | $9K | Hold |
150
| – | – | ﹤0.01% | 173 |
|
|
2015
Q1 | $10K | Hold |
150
| – | – | ﹤0.01% | 176 |
|
|
2014
Q4 | $9K | Hold |
150
| – | – | 0.01% | 192 |
|
|
2014
Q3 | $7K | Hold |
150
| – | – | ﹤0.01% | 187 |
|
|
2014
Q2 | $7K | Hold |
150
| – | – | ﹤0.01% | 183 |
|
|
2014
Q1 | $8K | Hold |
150
| – | – | 0.01% | 176 |
|
|
2013
Q4 | $8K | Hold |
150
| – | – | 0.01% | 184 |
|
|
2013
Q3 | $7K | Hold |
150
| – | – | ﹤0.01% | 192 |
|
|
2013
Q2 | $7K | Buy |
+150
| New | +$6.51K | 0.01% | 190 |
|
Other funds holding BMY
LMFP
AIM
FWIA
DLA
Financial Management Professionals's BMY Position: Q2 2026 in Review
Financial Management Professionals increased its Bristol-Myers Squibb (BMY) stake by 89% in Q2 2026, buying an estimated $2.7K and bringing the position to 100 shares worth $5.76K. The position accounts for ﹤0.01% of the portfolio, ranked #664.
Financial Management Professionals first reported a position in BMY in Q2 2013 and has held it in 53 quarters since. The position peaked at $415K in Q2 2022. 796 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Financial Management Professionals held 100 shares of Bristol-Myers Squibb worth $5.76K as of Q2 2026.
- Financial Management Professionals bought 47 Bristol-Myers Squibb shares in Q2 2026, an estimated $2.7K.
- Bristol-Myers Squibb made up ﹤0.01% of Financial Management Professionals's portfolio in Q2 2026, its #664 holding.
- Financial Management Professionals first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 53 quarters since.
- Financial Management Professionals's Bristol-Myers Squibb position peaked at $415K in Q2 2022.
- 796 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Financial Management Professionals's 13F filing for Q2 2026, filed 9 Jul 2026.